Welcome to the 21st WCP Virtual Congress Program Scheduling

The congress will officially run on Colombian Standard Time (UTC-5)

To convert the congress times to your local time Click Here         

        

Filter - Live Sessions: Plenary / Presidential Session   |   Courses   |  Special Sessions  |  Presidential Forum  |  Spanish Language Sessions |  State of the Art Sessions  |  Interorganizational Symposia  |  Original Sessions | Panel Discussions | Thematic Sessions

Filter - Recorded Sessions:  Accepted Symposia | Free Communications | WPA Distinguished Lectures

Displaying One Session

View

Hall C

State of the Art Session

STATE OF THE ART SESSION: DELIVERING BEST CARE FOR PATIENTS WITH SCHIZOPHRENIA: FROM EARLY INTERVENTION TO EFFECTIVE LONG-TERM TREATMENT

Session Type
State of the Art Session
Date
10/21/2021
Session Time
11:00 AM - 12:00 PM
Room
Hall C
Chair(s)
  • Peter Falkai (Germany)
Session Description
State-of-the-Art Symposium (SoAS) on delivering best care for patients with schizophrenia. Veronica Larach Reports on "Suspected first episode psychosis and accessibility : the role of primary care and the health network”. Wolfgang Gaebel reports on "Guideline-based longterm Treatment". Peter Falkai reports on "From early intervention to effective long-term Treatment".

SUSPECTED FIRST EPISODE PSYCHOSIS AND ACCESSIBILITY: THE ROLE OF PRIMARY CARE AND THE HEALTH NETWORK

Presenter
  • Veronica W. Larach (Chile)
Lecture Time
11:00 AM - 11:18 AM

GUIDELINE-BASED LONG-TERM TREATMENT

Presenter
  • Wolfgang H. Gaebel (Germany)
Lecture Time
11:18 AM - 11:36 AM

FROM EARLY INTERVENTION TO EFFECTIVE LONG-TERM TREATMENT

Presenter
  • Peter Falkai (Germany)
Lecture Time
11:36 AM - 11:54 AM

Abstract

Objectives

Schizophrenia is a severe brain disorder characterised by positive, negative, affective and cognitive symptoms and can be viewed as a disorder of impaired neural plasticity. Pharmacotherapy, psychotherapy and social therapy form a multi-facetted treatment for schizophrenia has helped considerably to improve the outcome of schizophrenia.


A thoughtful systematic combination of evidence-based pharmacotherapy (when to give what, how and how much), psychotherapy and socio-therapy is needed to reduce the number of partial remissions and non-remissions.

Reasons for this unfavourable outcome are the residual symptoms, mainly negative symptomatology and cognitive dysfunction. Reduced residual symptoms targeted add-on therapies are needed to improve the efficacy of the antipsychotics.

Taken together, evidence based therapy of schizophrenia comprises a lot of options to improve the outcome of this illness. A thoughtful combination of already present options as a first step followed by new developments as the second step seems the way to go forward.

Hide